-
Weisong Zhou,
Dustin R Dowell, Mark W Geraci,
Timothy S Blackwell,
Robert D Collins,
Vasiliy V Polosukhin,
William E Lawson,
Pingsheng Wu,
Thomas Sussan,
Shyam Biswal,
Kasia Goleniewska,
Jamye O'Neal,
Dawn C Newcomb,
Shinji Toki,
Jason D Morrow,
R Stokes Peebles
[show abstract]
[hide abstract]
ABSTRACT: The mortality rate for acute lung injury (ALI) is reported to be between 35-40%, and there are very few treatment strategies that improve the death rate from this condition. Previous studies have suggested that signaling through the prostaglandin (PG) I(2) receptor may protect against bleomycin-induced ALI in mice. We found that mice that overexpress PGI synthase (PGIS) in the airway epithelium were significantly protected against bleomycin-induced mortality and had reduced parenchymal consolidation, apoptosis of lung tissue, and generation of F(2)-isoprostanes compared with littermate wild-type controls. In addition, we show for the first time in both in vivo and in vitro experiments that PGI(2) induced the expression of NADP (H): quinoneoxidoreductase 1 (Nqo 1), an enzyme that prevents the generation of reactive oxygen species. PGI(2) induction of Nqo 1 provides a possible novel mechanism by which this prostanoid protects against bleomycin-induced mortality and identifies a potential therapeutic target for human ALI.
AJP Lung Cellular and Molecular Physiology 07/2011; 301(4):L615-22. · 3.66 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Signaling through the PGI(2) receptor (IP) has been shown to inhibit inflammatory responses in mouse models of respiratory syncytial viral infection and OVA-induced allergic responses. However, little is known about the cell types that mediate the anti-inflammatory function of PGI(2.) In this study, we determined that PGI(2) analogs modulate dendritic cell (DC) cytokine production, maturation, and function. We report that PGI(2) analogs (iloprost, cicaprost, treprostinil) differentially modulate the response of murine bone marrow-derived DC (BMDC) to LPS in an IP-dependent manner. The PGI(2) analogs decreased BMDC production of proinflammatory cytokines (IL-12, TNF-alpha, IL-1alpha, IL-6) and chemokines (MIP-1alpha, MCP-1) and increased the production of the anti-inflammatory cytokine IL-10 by BMDCs. The modulatory effect was associated with IP-dependent up-regulation of intracellular cAMP and down-regulation of NF-kappaB activity. Iloprost and cicaprost also suppressed LPS-induced expression of CD86, CD40, and MHC class II molecules by BMDCs and inhibited the ability of BMDCs to stimulate Ag-specific CD4 T cell proliferation and production of IL-5 and IL-13. These findings suggest that PGI(2) signaling through the IP may exert anti-inflammatory effects by acting on DC.
The Journal of Immunology 02/2007; 178(2):702-10. · 5.79 Impact Factor
-
Koichi Hashimoto,
Barney S Graham, Mark W Geraci,
Garret A FitzGerald,
Karine Egan,
Weisong Zhou,
Kasia Goleniewska,
Jamye F O'Neal,
Jason D Morrow,
Russell K Durbin,
Peter F Wright,
Robert D Collins,
Tatsuo Suzutani,
R Stokes Peebles
[show abstract]
[hide abstract]
ABSTRACT: The role of prostanoids in modulating respiratory syncytial virus (RSV) infection is unknown. We found that RSV infection in mice increases production of prostaglandin I(2) (PGI(2)). Mice that overexpress PGI(2) synthase selectively in bronchial epithelium are protected against RSV-induced weight loss and have decreased peak viral replication and gamma interferon levels in the lung compared to nontransgenic littermates. In contrast, mice deficient in the PGI(2) receptor IP have exacerbated RSV-induced weight loss with delayed viral clearance and increased levels of gamma interferon in the lung compared to wild-type mice. These results suggest that signaling through IP has antiviral effects while protecting against RSV-induced illness and that PGI(2) is a potential therapeutic target in the treatment of RSV.
Journal of Virology 11/2004; 78(19):10303-9. · 5.40 Impact Factor
